On September 19, Reshape Lifesciences Entered Into Exclusive License Agreement With Biorad Medysis Pvt. Ltd.;
Portfolio Pulse from Benzinga Newsdesk
ReShape Lifesciences Inc. has entered into an Exclusive License Agreement with Biorad Medysis Pvt. Ltd. to manufacture, commercialize and distribute the Obalon® Gastric Balloon System in several South Asian countries. Biorad will pay $200,000 upfront and 4% royalty on gross sales. Biorad is also expected to become the exclusive worldwide manufacturer and supplier of the Obalon Balloon System.
September 22, 2023 | 8:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
ReShape Lifesciences has secured a new revenue stream through its licensing agreement with Biorad Medysis. This could potentially boost its financial performance.
The licensing agreement with Biorad Medysis provides ReShape Lifesciences with an upfront payment and ongoing royalty payments, which will contribute to its revenue. Additionally, Biorad becoming the exclusive worldwide manufacturer and supplier of the Obalon Balloon System could potentially reduce manufacturing costs for ReShape Lifesciences.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100